Abstract
The daily or almost daily intake of monoanalgesics, analgesic and ergotamine combinations, or opioids may, in patients with primary headaches, cause a continuous headache, which is defined as “analgesic-induced rebound headache” (Andersson 1975; Hokkanen et al. 1978; Tfelt-Hausen and Krabbe 1981). This drug-induced headache occurs predominantly in patients suffering from migraine (Andersson 1975; Mathew et al. 1982; Wilkinson 1983) tension headache (Rapoport 1984; Ziegler 1985), or combination headache (which is a combination of migraine and tension headache) (Mathew 1981; Saper 1982; Pfaffenrath et al. 1986) and manifests itself, mainly at alternating sides and as a daily, partly throbbing, partly dull headache (Kudrow 1982; Rapoport 1984) with accompanying minor vegetative and visual symptoms. The analgesic-induced headache resembles the basic primary headache, and its differentiation from the latter causes major problems, both for the affected patient and the physician. It is maintained by a sometimes almost careless use of analgesics, by the patients fear of the next attack and finally by his addiction to the barbiturates and opioids contained in the compound preparations (Wörz 1983; Dichgans et al. 1984; Rapoport 1984). After a period of habituation due to the psychotropic effects of barbiturates and opioids, a psychophysical dependence results, which might be enhanced in individual cases by an abuse of tranquilizers.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Ad hoc Committee on classification of headache (1962) Classification of headache. JAMA 179: 717–718
Anderson PG (1975) Ergotamine headache. Headache 15: 118–121
Diamond S, Scheubaum H (1983) Flunarizine, a calcium-channel-blocker, in the prophylactic treatment of migraine. Headache 23: 39–42
Dichgans J, Diener HC, Gerber WD, Verspohl EJ, Kukiolka H, Kluck M (1984) Analgetica-induzierter Dauerkopfschmerz. Dtsch Med Wochenschr 109: 369–372
Hokkanen E, Waltimo O, Kallaranta T (1978) Toxic effects of ergotamine used for migraine. Headache 18: 95–98
Kudrow L (1979) Cluster headache. Diagnosis and management. Headache 19:142–149
Kudrow L (1982) Paradoxical effects of frequent analgesic use. In: Critchley M, Friedman AP, Gorini S, Sicuteri F (eds) Advances in Neurology, vol 33. Raven, New York, pp 335–342
Louis P, Spierings EHL (1982) Comparison of flunarizine (Sibelium) and pizotifen ( Sandomi-gran ). Cephalalgia 2: 197–203
Lundberg PO, Osterman PO (1974) The benign and malignant form of orgasmic cephalalgia. Headache 14: 164
Mathew NT (1981) Prophylaxis of migraine and mixed headache. A randomized controlled study. Headache 21: 235–239
Mathew NT, Stubits E, Nigam MP (1982) Transformation of episodic migraine into daily headache: analysis of factors. Headache 22: 66–68
Pfaffenrath V, Kellhammer U, Pöllmann W (1986) Combination headache: practical experience with a combination of a ß-blocker and an antidepressive. Cephalalgia, 6[suppl 51: 25–32
Rapoport AM (1984) Kopfschmerzen durch Analgetica. In: Pfaffenrath V, Schrader A, Neu IS (eds) Primäre Kopfschmerzen. MMW, München, pp 47–52
Saper JR (1982) The mixed headache syndrome. A new perspective. Headache 22: 184–186
Sjaastad O. (1986) Cluster Headache. In: Rose FC, Handbook of clinical neurology, vol 4, Headache. Elsevier, Amsterdam 48: 217–246
Sjaastad O., Dale I (1976) A new (?) clinical headache entity “chronic paroxysmal hemicrania.” Acta Neurol Scand 54: 140–159
Sjaastad O., Saunte C, Hovdahl H, Breivik H, Groenbaeck E (1983) Cervicogenic headache. An hypothesis. Cephalalgia 3: 249–256
Tfelt-Hansen P (1985) Ergotamine headache. In: Pfaffenrath V, Lundberg PO, Sjaastad O (eds) Updating in headache. Springer, Berlin Heidelberg New York Tokyo, pp 169–172
Tfelt-Hansen P, Krabbe AA (1981) Ergotamine abuse. Do patients benefit from withdrawal? Ce-phalalgia 1: 29–32
Weerasuriya K, Patel L, Turner P (1982) ß-Adrenoceptor blockade and migraine. Cephalalgia 2: 33–45
Welch KMA, Darney D, Simkins RT (1984) The role of estrogen in migraine: a review and hypothesis. Cephalalgia 4: 227–236
Wilkinson M (1983) Treatment of the acute migraine attack — current status. Cephalalgia 3: 61–67
Wörz R (1983) Effects and risks of psychotropic and analgesic combinations. Am J Med 75: 139–140
Ziegler DK (1985) Tension-muscle contraction headaches. A review. In: Pfaffenrath V, Lundberg PO, Sjaastad O (eds) Updating in headache. Springer, Berlin Heidelberg New York Tokyo, pp 315–320
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Pfaffenrath, V., Niederberger, U. (1988). What Kind of Drugs Are Taken by Patients with Primary Headaches?. In: Diener, HC., Wilkinson, M. (eds) Drug-Induced Headache. Advances in Applied Neurological Sciences, vol 5. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-73327-7_7
Download citation
DOI: https://doi.org/10.1007/978-3-642-73327-7_7
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-73329-1
Online ISBN: 978-3-642-73327-7
eBook Packages: Springer Book Archive